Alignment Healthcare (NASDAQ:ALHC) CEO John Kao Sells 73,046 Shares of Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) CEO John Kao sold 73,046 shares of the firm’s stock in a transaction dated Wednesday, March 18th. The shares were sold at an average price of $17.84, for a total transaction of $1,303,140.64. Following the completion of the sale, the chief executive officer owned 1,784,868 shares of the company’s stock, valued at $31,842,045.12. This trade represents a 3.93% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Alignment Healthcare Trading Down 0.2%

Shares of ALHC opened at $18.16 on Friday. Alignment Healthcare, Inc. has a twelve month low of $11.63 and a twelve month high of $23.87. The company has a current ratio of 1.71, a quick ratio of 1.71 and a debt-to-equity ratio of 1.80. The firm has a market capitalization of $3.71 billion, a P/E ratio of -1,814.19, a PEG ratio of 2.66 and a beta of 1.18. The firm’s 50-day moving average is $20.51 and its two-hundred day moving average is $18.78.

Alignment Healthcare (NASDAQ:ALHC) last released its quarterly earnings results on Thursday, February 26th. The company reported ($0.05) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.15) by $0.10. The business had revenue of $1.01 billion for the quarter, compared to analysts’ expectations of $1 billion. Alignment Healthcare had a negative return on equity of 0.49% and a negative net margin of 0.02%.The company’s revenue was up 44.4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted ($0.16) EPS. On average, research analysts predict that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current fiscal year.

Key Stories Impacting Alignment Healthcare

Here are the key news stories impacting Alignment Healthcare this week:

• Neutral Sentiment: Analyst comparison article — a Zacks piece compares ALHC to BrightSpring (BTSG) for value-oriented investors; useful for context but not an immediate catalyst. BTSG or ALHC: Which Is the Better Value Stock Right Now?
• Neutral Sentiment: Short-interest report appears to contain errors (reports 0 shares and “NaN” increases). The published data is not meaningful — do not treat it as evidence of rising short pressure until corrected by exchanges/brokers.
• Negative Sentiment: CEO John E. Kao sold 73,046 shares at an average $17.84 for ~$1.30M on Mar 18; his ownership fell ~3.93%. Filing: SEC Filing
• Negative Sentiment: President Dawn C. Maroney sold 36,749 shares at $17.84 (~$655.6k) on Mar 18; her stake dropped ~3.35%. Filing: SEC Filing
• Negative Sentiment: Insider Christopher J. Joyce sold 25,125 shares at $17.84 (~$448.2k) on Mar 18; his position fell ~7.21%. Filing: SEC Filing
• Negative Sentiment: Hyong Kim sold 18,404 shares at $17.84 (~$328.3k) on Mar 18; his holding declined ~4.77%. Filing: SEC Filing
• Negative Sentiment: COO Sebastian Burzacchi sold 15,361 shares at $17.84 (~$274.0k) on Mar 18; his stake fell ~5.61%. Filing: SEC Filing
• Negative Sentiment: Andreas P. Wagner executed two recent sales (12,000 @ $17.84 on Mar 18 and 11,602 @ $18.22 on Mar 19), ~23.6k shares total for ~ $425.5k, reducing his stake ~7%. Filing: SEC Filing
• Negative Sentiment: Robert L. Scavo sold 11,285 shares at $17.84 (~$201.3k) on Mar 18; his position dipped ~2.26%. Filing: SEC Filing

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of the business. T. Rowe Price Investment Management Inc. grew its stake in Alignment Healthcare by 0.6% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 12,643,784 shares of the company’s stock worth $249,715,000 after buying an additional 79,268 shares during the period. Invesco Ltd. raised its stake in shares of Alignment Healthcare by 38.9% in the 4th quarter. Invesco Ltd. now owns 6,202,592 shares of the company’s stock valued at $122,501,000 after acquiring an additional 1,735,962 shares during the period. Mercer Global Advisors Inc. ADV raised its stake in shares of Alignment Healthcare by 6.9% in the 4th quarter. Mercer Global Advisors Inc. ADV now owns 15,452 shares of the company’s stock valued at $305,000 after acquiring an additional 996 shares during the period. Mackenzie Financial Corp lifted its holdings in shares of Alignment Healthcare by 25.6% during the 4th quarter. Mackenzie Financial Corp now owns 46,917 shares of the company’s stock valued at $901,000 after acquiring an additional 9,552 shares in the last quarter. Finally, nVerses Capital LLC acquired a new position in shares of Alignment Healthcare during the 4th quarter valued at $396,000. Hedge funds and other institutional investors own 86.19% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have commented on ALHC. TD Cowen increased their target price on Alignment Healthcare from $18.50 to $25.00 and gave the company a “buy” rating in a report on Friday, January 16th. Weiss Ratings reissued a “sell (d-)” rating on shares of Alignment Healthcare in a research note on Wednesday, January 21st. UBS Group raised their price objective on Alignment Healthcare from $18.00 to $21.00 and gave the stock a “neutral” rating in a report on Wednesday, January 14th. Piper Sandler raised their price target on Alignment Healthcare from $20.00 to $30.00 and gave the stock an “overweight” rating in a research note on Tuesday, January 6th. Finally, KeyCorp restated an “overweight” rating and issued a $28.00 target price on shares of Alignment Healthcare in a report on Thursday, January 22nd. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $24.56.

About Alignment Healthcare

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.